Live, queryable views of official open data — refreshed automatically, transparent about their sources, free to use. Three are live today, covering oncology drug approvals, cancer clinical trials worldwide, and research funding for cancer care.
Every new oncology & haematology drug approval from the FDA and EMA, 2016 to today. Filter by tumour stream or medicine, and compare FDA vs EMA approvals side by side — the clearest view of how the two regulators diverge. Official open data, refreshed weekly.
Interventional oncology trials worldwide, first-registered within the last three years, from ClinicalTrials.gov. Filter by therapy type, sponsor, phase, status, tumour stream, country and trial design, and open any row for its primary and key secondary endpoints. Refreshed monthly.
Open and upcoming research funding calls on the quality, organisation, economics and sustainability of cancer care — across EU programmes, Dutch funders, other European and Australian funders, and cancer charities. Filter by region and theme, see what closes soonest, and open any call on the funder’s own page. Rescanned monthly.
Each tracker is built directly from official open data — the FDA and EMA registers, ClinicalTrials.gov, the funders’ own call pages — is transparent about its sources, and updates itself on a schedule. No scraping, no black boxes. Looking for our own analytical tools instead? They live under Tools.
Suggest a tracker